Vioxx and Generalized anxiety disorder - a phase IV clinical study of FDA data

Summary:

Generalized anxiety disorder is found among people who take Vioxx, especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Vioxx and have Generalized anxiety disorder. It is created by eHealthMe based on reports of 109,817 people who have side effects when taking Vioxx from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 21, 2023

109,817 people reported to have side effects when taking Vioxx.
Among them, 561 people (0.51%) have Generalized anxiety disorder.

What is Vioxx?

Vioxx has active ingredients of rofecoxib. It is often used in arthritis. eHealthMe is studying from 109,849 Vioxx users for its effectiveness, alternative drugs and more.

What is Generalized anxiety disorder?

Generalized anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry) is found to be associated with 1,810 drugs and 1,388 conditions by eHealthMe.

Number of Vioxx and Generalized anxiety disorder reports submitted per year:

Could Vioxx cause Generalized anxiety disorder?

* Approximation only. Some reports may have incomplete information.

Do you take Vioxx and have Generalized anxiety disorder?

Check whether Generalized anxiety disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Ahmed AB, Radwan AM, Baddary HM, "Prevalence of Generalized Anxiety Disorder in Patients with Rheumatoid Arthritis and its Relationship with Disease Activity", The Egyptian Journal of Hospital Medicine, 2016 Jan .

Related studies

How severe was Generalized anxiety disorder and when was it recovered:

Generalized anxiety disorder in Vioxx

Expand to all the drugs that have ingredients of rofecoxib:

Generalized anxiety disorder and drugs with ingredients of rofecoxib (573 reports)

Alternative drugs to, pros and cons of Vioxx:

Vioxx (109,849 reports)

Common Vioxx side effects:

Browse all side effects of Vioxx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Generalized anxiety disorder treatments and more:

Generalized anxiety disorder (28,387 reports)

COVID vaccines that are related to Generalized anxiety disorder:

Common drugs associated with Generalized anxiety disorder:

All the drugs that are associated with Generalized anxiety disorder:

Generalized anxiety disorder (1,810 drugs)

Common conditions associated with Generalized anxiety disorder:

Depression: 487 reports
Osteoporosis: 429 reports
High blood pressure: 403 reports
Pain: 399 reports
Stress and anxiety: 374 reports

All the conditions that are associated with Generalized anxiety disorder:

Generalized anxiety disorder (1,388 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rofecoxib (the active ingredients of Vioxx) and Vioxx (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.